Literature DB >> 1780048

Pattern recognition in magnetic resonance imaging of white matter disorders in children and young adults.

M S van der Knaap1, J Valk, N de Neeling, J J Nauta.   

Abstract

Magnetic resonance imaging (MRI) is considered to be a highly sensitive modality for visualizing white matter abnormalities. Estimations of its specificity are far less positive. However, diagnostic specificity depends upon both the inherent qualities of MRI and on the quality of image interpretation. Systematic and detailed analysis of many image elements, and substantial prior experience improve the quality of image interpretation and thus improve diagnostic specificity. The present study has been set up to develop a pattern recognition system which combines sensitivity and specificity, systematic analysis of image elements and prior experience. This pattern recognition is based on the data of 277 patients with white matter disorders referred for MRI. The information was stored in a data base and computer analyzed. Twenty-two MRI patterns were discerned in as many disease categories. The frequency of occurrence of each MRI abnormality was assessed per disease category to establish the pattern of abnormalities characteristic for each separate disease category. The pattern recognition program was also written so that: (a) when fed data about MRI abnormalities observed in a new case, the computer produces a differential diagnosis with probabilities and 95% confidence intervals for each differential diagnosis; (b) specific data on the MRI findings of new cases could be added to the data base to improve the experience and accuracy of the program. This program for pattern recognition of abnormalities in the MR images of white matter disorders enhances the specificity of image interpretation and provides a wonderful aid for teaching purposes.

Entities:  

Mesh:

Year:  1991        PMID: 1780048     DOI: 10.1007/bf00588038

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  49 in total

1.  Enhanced interpretation of diagnostic images.

Authors:  D J Getty; R M Pickett; C J D'Orsi; J A Swets
Journal:  Invest Radiol       Date:  1988-04       Impact factor: 6.016

2.  Leucoencephalopathy after inhaling "heroin" pyrolysate.

Authors:  E C Wolters; G K van Wijngaarden; F C Stam; H Rengelink; R J Lousberg; M E Schipper; B Verbeeten
Journal:  Lancet       Date:  1982-12-04       Impact factor: 79.321

3.  CT and MR of MELAS syndrome.

Authors:  J C Allard; S Tilak; A P Carter
Journal:  AJNR Am J Neuroradiol       Date:  1988 Nov-Dec       Impact factor: 3.825

4.  MR of Leigh's disease (subacute necrotizing encephalomyelopathy).

Authors:  P C Davis; J C Hoffman; I F Braun; P Ahmann; N Krawiecki
Journal:  AJNR Am J Neuroradiol       Date:  1987 Jan-Feb       Impact factor: 3.825

5.  Magnetic resonance imaging of inflammatory and demyelinating white-matter diseases of childhood.

Authors:  D H Miller; S A Robb; I E Ormerod; K R Pohl; D G MacManus; B E Kendall; I F Moseley; W I McDonald
Journal:  Dev Med Child Neurol       Date:  1990-02       Impact factor: 5.449

6.  Periventricular leukomalacia in adults. Clinicopathological study of four cases.

Authors:  J L De Reuck; H M Eecken
Journal:  Arch Neurol       Date:  1978-08

7.  MRI in Cockayne syndrome type I.

Authors:  E Boltshauser; C Yalcinkaya; W Wichmann; F Reutter; A Prader; A Valavanis
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

8.  Partial deletion of the long arm of chromosome 11 [del(11)(q23.3----qter)] with abnormal white matter.

Authors:  T D Wardinsky; E Weinberger; R A Pagon; S K Clarren; H C Thuline
Journal:  Am J Med Genet       Date:  1990-01

9.  Cockayne syndrome: magnetic resonance images of the brain in a severe form with early onset.

Authors:  H Nishio; S Kodama; T Matsuo; M Ichihashi; H Ito; Y Fujiwara
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

View more
  22 in total

Review 1.  [Cerebral CT and MRI in mitchondrial disorders].

Authors:  J Finsterer
Journal:  Nervenarzt       Date:  2009-06       Impact factor: 1.214

Review 2.  [Demyelinating disorders].

Authors:  T Weber; W Köhler
Journal:  Nervenarzt       Date:  2010-04       Impact factor: 1.214

3.  Alexander disease: diagnosis with MR imaging.

Authors:  M S van der Knaap; S Naidu; S N Breiter; S Blaser; H Stroink; S Springer; J C Begeer; R van Coster; P G Barth; N H Thomas; J Valk; J M Powers
Journal:  AJNR Am J Neuroradiol       Date:  2001-03       Impact factor: 3.825

Review 4.  Medical diagnostic decision support systems--past, present, and future: a threaded bibliography and brief commentary.

Authors:  R A Miller
Journal:  J Am Med Inform Assoc       Date:  1994 Jan-Feb       Impact factor: 4.497

5.  Leukoencephalopathy with swelling in children and adolescents: MRI patterns and differential diagnosis.

Authors:  M S van der Knaap; J Valk; P G Barth; L M Smit; B G van Engelen; P Tortori Donati
Journal:  Neuroradiology       Date:  1995-11       Impact factor: 2.804

6.  New syndrome characterized by hypomyelination with atrophy of the basal ganglia and cerebellum.

Authors:  Marjo S van der Knaap; SakkuBai Naidu; Petra J W Pouwels; Simona Bonavita; Rudy van Coster; Lieven Lagae; Jürgen Sperner; Robert Surtees; Raphael Schiffmann; Jakob Valk
Journal:  AJNR Am J Neuroradiol       Date:  2002-10       Impact factor: 3.825

Review 7.  Proton magnetic resonance spectroscopy in brain white matter disorders.

Authors:  N De Stefano; A Federico; D L Arnold
Journal:  Ital J Neurol Sci       Date:  1997-12

8.  Invited article: an MRI-based approach to the diagnosis of white matter disorders.

Authors:  Raphael Schiffmann; Marjo S van der Knaap
Journal:  Neurology       Date:  2009-02-24       Impact factor: 9.910

9.  GM-2 gangliosidosis (Sandhoff's disease): two year follow-up by MRI.

Authors:  W Koelfen; M Freund; W Jaschke; S Koenig; C Schultze
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

Review 10.  Neuroimaging in mitochondrial disorders.

Authors:  Andrea L Gropman
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.